Indiana Attorney General Greg Zoeller’s office has filed a formal complaint against the Massachusetts based pharmacy linked to last year’s meningitis outbreak.
The complaint was filed with the Indiana Pharmacy Board, the licensing agency responsible for allowing the New England Compounding Center to operate in the state of Indiana.
In November, the Indiana Board of Pharmacy voted to indefinitely suspend NECC’s non-resident pharmacy license. In a statement, Zoeller said the board will consider the formal complaint at its next meeting on Feb. 11.
“This pharmacy failed to ensure its epidural steroid injections were safe for patients which led to devastating harm,” he says. “This formal licensing complaint against the New England Compounding Center will soon be considered by the Indiana Board of Pharmacy which has the authority to determine the appropriate discipline.”
In September, the CDC in coordination with the Food and Drug Administration identified the NECC as the compounding pharmacy that produced the epidural steroid injections that caused the onset of meningitis in certain patients. Shortly after, NECC ceased production and initiated a recall of the drugs.